These Stem Cell Markets Are Seeing Massive Growth

The global stem cell markets are forecast to reach US $63.8 billion by 2015 from an estimated value of US $21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015.

In terms of drug discovery applications using stem cells, North America and Europe account for more than 60% of the stem cell markets value. However, the largest growth rate during 2009-2015 is expected from Asia-Pacific, a CAGR (Compound annual growth rate) of 26.5%. China, India, Greece, Spain, Sweden, Germany and the US are at the forefront in driving the sector growth with an annual growth rate of more than 27% during the period.

Brazil and Argentina are the Latin American majors in drug discovery applications using stem cells. Stem cells use in replacing damaged cells is expected to witness highest investments in the upcoming years as the CAGR forecasts for the sector is high. Estimates for cell therapy and regenerative medicine market indicate a CAGR of nearly 24% CAGR during 2009-2015.

Global stem cell nutrition education is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015.

The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead of other stem cell markets..

Improving health consciousness in Europe will likely maintain the stem cell technology and science expansion of the European Union competent with Asia-Pacific/North America.

India possesses the potential to occupy the leading position in stem cell technology growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015.

Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate in stem cell marketing in the next few years.

Many leading companies are tracking the pulse of the exploding stem cell nutrition markets of the world. One such company is Adult stem cell nutrition company, STEMTech HealthScience. STEMTech is the world’s first stem cell nutrition company. STEMTech was founded in 2005, but the company’s story begins decades earlier with the discovery of Aphanizomenon flos-aquae (AFA) in the 1970s.

STEMTech has since grown their stem cell nutrition markets from a World Headquarters and a warehouse in the USA, to many offices and Vice Presidents, in over 20 countries on 6 continents .

STEMTech is in Germany, Malaysia, Canada, South Africa, Namibia, Columbia, Mexico, France, Japan, Spain, Ghana, United Kingdom, Bulgaria, Philippines, Jamaica, Puerto Rico, Taiwan, Australia, New Zealand and soon.. India.

2009 proved to be a big year for stem cell markets..and for STEMTech. In addition to establishing a solid reputation as the global leader in adult stem cell nutrition, STEMTech was chosen as one of three finalists for the US Direct Selling Association’s prestigious Rising Star award.

Following industry wide accolades a year earlier, STEMTech received national recognition in 2010 by making Inc.’s coveted Inc. 5,000 list of fastest-growing privately held companies in America (STEMTech was ranked 1,484 out of over 29 million companies).

STEMTech officials and leaders are always tracking the GLOBAL Stem Cell Nutrition Market potential. VIEW some of the global stem cell markets HERE